3rd Next Generation RNA Therapeutics Summit | May 7-9,, 2024 | Boston, MA

Kongressthemen
Pioneering the Next Breakthrough in Durable and Potent RNA Therapeutics for Patients

The field of next generation RNA therapeutics continues to progress towards clinical translation, with enormous investments and collaborations, such as Orbital Therapeutics’ recent $270 million Series A financing.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
URL:
Brochure: https://go.evvnt.com/2128086-3?pid=4832

Speakers: Anthony Saleh, Co-founder and Chief Executive Officer, MiRecule Inc., Daiki Matsuda, Director, Capstan Therapeutics, Dan Shores, Partner, Rothwell Figg, and more

https://go.evvnt.com/2128086-2?pid=4832

Frau Rosie Andre